Zhang DL - Search Results

1

TPX2 enhances the transcription factor activation of PXR and enhances the resistance of hepatocellular carcinoma cells to antitumor drugs.

Wang H, Chu F, Zhang XF, Zhang P, Li LX, Zhuang YL, Niu XF, He X, Li ZJ, Bai Y, Mao D, Liu ZW, Zhang DL, Li BA. Wang H, et al. Among authors: zhang p, zhang dl, zhang xf. Cell Death Dis. 2023 Jan 27;14(1):64. doi: 10.1038/s41419-022-05537-7. Cell Death Dis. 2023. PMID: 36707511 Free PMC article.

2

[Short-term efficacy of Harvoni in treatment of hepatitis C after liver transplantation].

Zhou SN, Zhang N, Liu ZW, Zhang DL, Tang RJ, Su HB, Zhang M. Zhou SN, et al. Among authors: zhang n, zhang m, zhang dl. Zhonghua Gan Zang Bing Za Zhi. 2016 May 20;24(5):392-4. doi: 10.3760/cma.j.issn.1007-3418.2016.05.017. Zhonghua Gan Zang Bing Za Zhi. 2016. PMID: 27470897 Chinese. No abstract available.

3

Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation.

Liu H, He X, Wang Y, Zhou S, Zhang D, Zhu J, He Q, Zhu Z, Li G, Sun L, Wang J, Cheng G, Liu Z, Lau G. Liu H, et al. Hepatol Int. 2020 Jul;14(4):432-436. doi: 10.1007/s12072-020-10043-z. Epub 2020 Apr 10. Hepatol Int. 2020. PMID: 32277387 Free PMC article.

4

Preoperative serum hepatitis B virus DNA was a risk factor for hepatocellular carcinoma recurrence after liver transplantation.

Zhang D, Feng D, Ren M, Bai Y, Liu Z, Wang H. Zhang D, et al. Ann Med. 2022 Dec;54(1):2213-2221. doi: 10.1080/07853890.2022.2107233. Ann Med. 2022. PMID: 35930293 Free PMC article.

5

The Combination of AFP and "Up-To-Seven" Criteria May Be a Better Strategy for Liver Transplantation in Chinese Cirrhotic HCC Patients.

Zhang DL, Feng DN, He X, Zhang XF, Li LX, Li ZJ, Niu XF, Zhuang YL, Liu ZW, Gao XD, Wang HB. Zhang DL, et al. Among authors: zhang xf. Front Oncol. 2022 Jul 12;12:959151. doi: 10.3389/fonc.2022.959151. eCollection 2022. Front Oncol. 2022. PMID: 35936699 Free PMC article.

6

MTBP enhances the activation of transcription factor ETS-1 and promotes the proliferation of hepatocellular carcinoma cells.

Wang H, Chu F, Zhijie L, Bi Q, Lixin L, Zhuang Y, Xiaofeng Z, Niu X, Zhang D, Xi H, Li BA. Wang H, et al. Front Oncol. 2022 Aug 29;12:985082. doi: 10.3389/fonc.2022.985082. eCollection 2022. Front Oncol. 2022. PMID: 36106099 Free PMC article.

7

Re: Risk Factors of Acute Kidney Injury Following Orthotopic Liver Transplantation.

Zhang D, Liu Z, Bi JF, Liu H, Gao Y. Zhang D, et al. Turk J Gastroenterol. 2022 Sep;33(9):809-810. doi: 10.5152/tjg.2022.216622. Turk J Gastroenterol. 2022. PMID: 36892051 Free article. No abstract available.

8

Total bile acid as a preoperative risk factor for post-hepatectomy liver failure in patients with hepatocellular carcinoma and normal bilirubin.

He X, Zhang X, Li Z, Niu X, Li L, Liu Z, Ren H, Zhang D. He X, et al. Cir Esp (Engl Ed). 2024 Dec;102(12):642-648. doi: 10.1016/j.cireng.2024.09.007. Epub 2024 Oct 10. Cir Esp (Engl Ed). 2024. PMID: 39393491

9

Effect of CYP 3A4*1B and CYP3A5*3 Gene Polymorphisms in Antirejection of Tacrolimus in Liver Transplant Patients.

Zhou X, Tang R, Zhang D, He X, Liu Z, Gao Y, Liu H. Zhou X, et al. Transplant Proc. 2024 Dec 5:S0041-1345(24)00563-3. doi: 10.1016/j.transproceed.2024.10.030. Online ahead of print. Transplant Proc. 2024. PMID: 39643490

10

Efficacy and safety of low accelerating dose regimen of interferon/ribavirin antiviral therapy in patients with hepatitis C virus recurrence after liver transplantation.

Su H, Liu Z, Sun Y, Li H, Zhou S, Zhou X, Gao Y, Tang R, Zhang D, Zhang M. Su H, et al. Ann Transplant. 2015 May 11;20:263-8. doi: 10.12659/AOT.892255. Ann Transplant. 2015. PMID: 25975740 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

508 results

Search Page

Filters